Smart deals start with the right connections.
Access 800+ qualified LPs through CQ’s Investor Database.
Overview and Management
Establishment Year
2018
Mission
To connect early-stage investors with promising radiopharmaceutical projects, facilitating their development through manufacturing and clinical trials, with a focus on Theranostics and oncology.
Values
Combination of scientific guidance, financial expertise, and sustainable organizational structures to support emerging radiopharmaceutical companies.
Investment Roles
General Partner (GP)
Participant Demographics
Scientists, early-stage investors, and licensing partners in the radiopharmaceutical industry.
Generational Wealth Planning
Risk Tolerance
Medium-risk investments with a focus on high-return opportunities.
References or Case Studies
Proven track record of building successful radiopharmaceutical startups, including OctreoPharm Sciences GmbH.
Team Experience
Proven expertise in clinical development, manufacturing, and financial management of radiopharmaceutical startups.
Notable Achievements
Successful establishment of radiopharmaceutical companies, including OctreoPharm Sciences GmbH.
Project Track Record
Focus on oncology and Theranostics with successful project exits.
Exit Strategies
Out-licensing projects to strategic partners.
Legal, Compliance and Contact Information
Regulatory Registrations
GDPR-compliant.
Compliance History
No major violations mentioned.
info@1717lsv.com
Phone Number
+49 30 94 1084 422
Address
Berlin Germany